Global Automation in Biopharmaceutical Market Insights, Forecast to 2025
Global Automation in Biopharmaceutical market size will reach 1590 million US$ by 2025, from 1040 million US$ in 2018, at a CAGR of 6.2% during the forecast period.
(EMAILWIRE.COM, January 03, 2019 ) The global biopharmaceutical industry is the most rapidly growing industry in the science and technology sector owing to increasing R&D investments in biopharmaceutical drug development facilities. The global automation market in biopharmaceutical industry includes deployment of automation in biopharmaceutical academic research centers, manufacturing and research companies, clinical labs, and government approved labs.
One trend in the market is continuous manufacturing. Advantages of continuous operations are well-recognized in various industries. It completes the process in a shorter time as it omits the hold steps, reduces shut down time, and reduces the labor requirement. Over the decades, upstream processing utilized this technology.
According to the report, one driver in the market is use of automation in data acquisition. Traditionally, research labs collect data manually and store it in spreadsheets. This method is not only time-consuming but also affects operational efficiency and is prone to errors. It also restricts monitoring of data in real time. The biopharmaceutical industry is working on data collection and adding the information from spreadsheets to a database. Database collection of upstream and downstream processes is being utilized to create a library that increases operational efficiency and process optimization.
Further, the report states that one challenge in the market is high R&D cost. The biopharmaceutical industry is a rapidly growing industry in pharmaceuticals. Complex drugs are manufactured with the help of 3-D modeling and are produced with high efficacy and precision. These drugs can provide medication to medical issues that were once incurable. Currently, the biopharmaceutical industry is looking to yield new products to address diseases such as cancer, Alzheimer's disease, and hepatitis C. Innovations in the biopharmaceutical industry are highly expensive. The average cost associated with a new drug is around $2 billion, including the cost of unsuccessful drug approvals, out of which almost $400 million is the cost included in pre-clinical and clinical testing.
Get Sample Copy of this Report@ https://www.orbisresearch.com/contacts/request-sample/2444721
This industry study presents the global Automation in Biopharmaceutical market size, historical breakdown data (2014-2019) and forecast (2019-2025). The Automation in Biopharmaceutical production, revenue and market share by manufacturers, key regions and type;
The consumption of Automation in Biopharmaceutical in volume terms are also provided for major countries (or regions), and for each application and product at the global level. Market share, growth rate, and competitive factors are also evaluated for market leaders Danaher, GE, etc.
The following manufacturers are covered in this report:
Danaher
GE
PerkinElmer
Tecan Trading
Thermo Fisher Scientific
Bruker
Peak Analysis & Automation
Waters
Capsugel
RheoSense
Eirechrom
BioProcess International
Novasep
Automation in Biopharmaceutical Breakdown Data by Type:
Clinical stage automation
Drug discovery stage automation
Automation in Biopharmaceutical Breakdown Data by Application:
Research and Development
Clinical
The study objectives of this report are:
To analyze and research the global Automation in Biopharmaceutical status and future forecast involving, production, revenue, consumption, historical and forecast.
To present the key Automation in Biopharmaceutical manufacturers, production, revenue, market share, SWOT analysis and development plans in next few years.
To segment the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Make an Inquiry before Buying this Report@ https://www.orbisresearch.com/contacts/enquiry-before-buying/2444721
Key Points from TOC:
Chapter One: Study Coverage
Chapter Two: Executive Summary
Chapter Three: Market Size by Manufacturers
Chapter Four: Automation in Biopharmaceutical Production by Regions
Chapter Five: Automation in Biopharmaceutical Consumption by Regions
Chapter Six: Market Size by Type
Chapter Seven: Market Size by Application
Chapter Eight: Key Industry Players
8.1 Danaher
8.1.1 Danaher Company Details
8.1.2 Production and Revenue of Automation in Biopharmaceutical
8.1.3 Danaher Automation in Biopharmaceutical Product Description
8.1.4 SWOT Analysis
8.1.5 Danaher Economic Activity & Plans
8.2 GE
8.2.1 GE Company Details
8.2.2 Production and Revenue of Automation in Biopharmaceutical
8.2.3 GE Automation in Biopharmaceutical Product Description
8.2.4 SWOT Analysis
8.2.5 GE Economic Activity & Plans
8.3 PerkinElmer
8.3.1 PerkinElmer Company Details
8.3.2 Production and Revenue of Automation in Biopharmaceutical
8.3.3 PerkinElmer Automation in Biopharmaceutical Product Description
8.3.4 SWOT Analysis
8.3.5 PerkinElmer Economic Activity & Plans
Continued
One trend in the market is continuous manufacturing. Advantages of continuous operations are well-recognized in various industries. It completes the process in a shorter time as it omits the hold steps, reduces shut down time, and reduces the labor requirement. Over the decades, upstream processing utilized this technology.
According to the report, one driver in the market is use of automation in data acquisition. Traditionally, research labs collect data manually and store it in spreadsheets. This method is not only time-consuming but also affects operational efficiency and is prone to errors. It also restricts monitoring of data in real time. The biopharmaceutical industry is working on data collection and adding the information from spreadsheets to a database. Database collection of upstream and downstream processes is being utilized to create a library that increases operational efficiency and process optimization.
Further, the report states that one challenge in the market is high R&D cost. The biopharmaceutical industry is a rapidly growing industry in pharmaceuticals. Complex drugs are manufactured with the help of 3-D modeling and are produced with high efficacy and precision. These drugs can provide medication to medical issues that were once incurable. Currently, the biopharmaceutical industry is looking to yield new products to address diseases such as cancer, Alzheimer's disease, and hepatitis C. Innovations in the biopharmaceutical industry are highly expensive. The average cost associated with a new drug is around $2 billion, including the cost of unsuccessful drug approvals, out of which almost $400 million is the cost included in pre-clinical and clinical testing.
Get Sample Copy of this Report@ https://www.orbisresearch.com/contacts/request-sample/2444721
This industry study presents the global Automation in Biopharmaceutical market size, historical breakdown data (2014-2019) and forecast (2019-2025). The Automation in Biopharmaceutical production, revenue and market share by manufacturers, key regions and type;
The consumption of Automation in Biopharmaceutical in volume terms are also provided for major countries (or regions), and for each application and product at the global level. Market share, growth rate, and competitive factors are also evaluated for market leaders Danaher, GE, etc.
The following manufacturers are covered in this report:
Danaher
GE
PerkinElmer
Tecan Trading
Thermo Fisher Scientific
Bruker
Peak Analysis & Automation
Waters
Capsugel
RheoSense
Eirechrom
BioProcess International
Novasep
Automation in Biopharmaceutical Breakdown Data by Type:
Clinical stage automation
Drug discovery stage automation
Automation in Biopharmaceutical Breakdown Data by Application:
Research and Development
Clinical
The study objectives of this report are:
To analyze and research the global Automation in Biopharmaceutical status and future forecast involving, production, revenue, consumption, historical and forecast.
To present the key Automation in Biopharmaceutical manufacturers, production, revenue, market share, SWOT analysis and development plans in next few years.
To segment the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Make an Inquiry before Buying this Report@ https://www.orbisresearch.com/contacts/enquiry-before-buying/2444721
Key Points from TOC:
Chapter One: Study Coverage
Chapter Two: Executive Summary
Chapter Three: Market Size by Manufacturers
Chapter Four: Automation in Biopharmaceutical Production by Regions
Chapter Five: Automation in Biopharmaceutical Consumption by Regions
Chapter Six: Market Size by Type
Chapter Seven: Market Size by Application
Chapter Eight: Key Industry Players
8.1 Danaher
8.1.1 Danaher Company Details
8.1.2 Production and Revenue of Automation in Biopharmaceutical
8.1.3 Danaher Automation in Biopharmaceutical Product Description
8.1.4 SWOT Analysis
8.1.5 Danaher Economic Activity & Plans
8.2 GE
8.2.1 GE Company Details
8.2.2 Production and Revenue of Automation in Biopharmaceutical
8.2.3 GE Automation in Biopharmaceutical Product Description
8.2.4 SWOT Analysis
8.2.5 GE Economic Activity & Plans
8.3 PerkinElmer
8.3.1 PerkinElmer Company Details
8.3.2 Production and Revenue of Automation in Biopharmaceutical
8.3.3 PerkinElmer Automation in Biopharmaceutical Product Description
8.3.4 SWOT Analysis
8.3.5 PerkinElmer Economic Activity & Plans
Continued
Contact Information:
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results